Avalo Therapeutics (AVTX) Earnings Date, Estimates & Call Transcripts $11.54 -0.10 (-0.86%) (As of 07/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 13) -$5.98 Missed By -$4.80 Consensus EPS (May. 13) -$1.18 Get Avalo Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AVTX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAVTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AVTX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Awesomely, LLCAutomatic Income (from home)Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…Watch this short video Avalo Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($28.11) EPSNext Year EPS Consensus Estimate: ($1.00) EPSAVTX Earnings Date and InformationAvalo Therapeutics last announced its quarterly earnings results on May 13th, 2024. The reported ($5.98) earnings per share for the quarter, missing the consensus estimate of ($1.18) by $4.80. Avalo Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Avalo Therapeutics are expected to grow in the coming year, from ($28.11) to ($1.00) per share. Avalo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Avalo Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/13/2024Q1 2024($1.18)($5.98)($4.80)$129.04--11/9/2023Q3 2023($264.00)($26.40)+$237.60($0.11)$1.00 million$0.24 million8/3/2023Q2 2023($216.00)($141.60)+$74.40($0.59)$1.00 million$0.64 million5/4/2023Q1 2023($232.80)($204.00)+$28.80($0.85)$1.00 million$0.48 million3/29/2023Q4 2022($124.80)($249.60)($124.80)($1.04)$5.20 million$0.90 million11/7/2022Q3 2022($247.20)$81.60+$328.80$0.34$1.40 million$14.95 million Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($432.00)($331.20)+$100.80($1.38)-$1.03 million5/5/2022Q1 2022($33.60)($48.00)($14.40)($0.20)-$1.17 million3/2/2022Q4 2021($432.00)($460.80)($28.80)---11/9/2021Q3 2021($518.40)($489.60)+$28.80($0.17)-$1.35 million8/2/2021Q2 2021($518.40)($518.40)-($0.18)-$3.36 million5/13/2021Q1 2021($662.40)($921.60)($259.20)($0.32)-$0.47 million11/9/2020Q3 2020($288.00)($460.80)($172.80)($0.15)$1.50 million$1.11 million8/6/2020Q2 2020($288.00)($432.00)($144.00)($0.11)$2.25 million$1.34 million5/7/2020Q1 2020($345.60)($115.20)+$230.40$0.26$2.25 million$2.75 million11/14/2019Q3 2019($489.60)($201.60)+$288.00($0.07)$5.15 million$5.61 million8/8/2019Q2 2019($460.80)($374.40)+$86.40($0.15)$5.28 million$4.45 million Avalo Therapeutics Earnings - Frequently Asked Questions When is Avalo Therapeutics's earnings date? Avalo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on AVTX's earnings history. Did Avalo Therapeutics beat their earnings estimates last quarter? In the previous quarter, Avalo Therapeutics (NASDAQ:AVTX) missed the analysts' consensus estimate of ($1.18) by $4.80 with a reported earnings per share (EPS) of ($5.98). Learn more on analysts' earnings estimate vs. AVTX's actual earnings. How much revenue does Avalo Therapeutics generate each year? Avalo Therapeutics (NASDAQ:AVTX) has a recorded annual revenue of $1.92 million. How much profit does Avalo Therapeutics generate each year? Avalo Therapeutics (NASDAQ:AVTX) has a recorded net income of -$31.54 million. AVTX has generated $0.00 earnings per share over the last four quarters. What is Avalo Therapeutics's EPS forecast for next year? Avalo Therapeutics's earnings are expected to grow from ($28.11) per share to ($1.00) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Vincerx Pharma Earnings Results GlycoMimetics Earnings Results Sol-Gel Technologies Earnings Results OncoCyte Earnings Results Reneo Pharmaceuticals Earnings Results Lexaria Bioscience Earnings Results Carisma Therapeutics Earnings Results Kezar Life Sciences Earnings Results NextCure Earnings Results YS Biopharma Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Leading Healthcare Provider Stock Soars on Earnings BeatViking Therapeutics: Pharma Stock Soars on Positive EarningsEarnings Season Sell-Off: Is This Tech Giant a Buy?Pharma Leader Beats on Earnings, But Shares FallSemiconductor Giant Posts Big Earnings Beat, but Shares Stay FlatIs This Industrial Stock a Buy After Recent Earnings Boost?Consumer Staple Stock's Q2 Earnings: Key Surprises and Challenges This page (NASDAQ:AVTX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.